文献速递神经免疫

解锁多发性硬化遗传学:从易感性到严重程度

Unlocking Multiple Sclerosis Genetics: From Susceptibility to Severity.
PubMed 文献 · Neurology · 2025-09-26

本文综述多发性硬化(MS)遗传因素从疾病易感性到严重程度的作用,指出已识别超过230个遗传变异提示外周免疫细胞在发病中的作用,而严重程度变异富集于中枢神经系统组织,提示两者遗传架构至少部分不同。

要点

  • MS风险基因主要涉及外周免疫细胞,已识别超过230个遗传变异。
  • HLA-DRB1*1501与疾病活动性的关联需用长期纵向队列重新评估。
  • 严重程度变异富集于中枢神经系统组织,与风险基因架构不同。

核心结论

  • MS风险与严重程度至少部分具有不同的遗传架构。

研究设计与样本

  • 综述,评估遗传因素在MS从疾病易感性到疾病严重程度中的作用。

主要发现

  • 已识别超过230个遗传变异提示外周免疫细胞在MS发病中的作用。
  • MS风险基因与疾病严重程度结局关联甚微。
  • 发现首个与年龄相关MS严重程度关联的遗传变异rs10191329及其病理关联。
  • MS严重程度变异富集于中枢神经系统组织。

关键数值与推荐

  • 已识别超过230个遗传变异提示外周免疫细胞在MS发病中的作用。
  • 主要MS风险等位基因HLA-DRB1*1501与疾病活动性的关联需用长期纵向队列观察重新评估。
  • 发现首个与年龄相关MS严重程度关联的遗传变异rs10191329。
  • MS严重程度变异富集于中枢神经系统组织。

临床怎么用

  • 遗传分析有望为进展型MS提供临床可用预测模型和机制靶点。

局限性

  • 复制研究面临统计效力低、残疾结局方法学差异以及治疗和疾病时间性差异的潜在影响。
  • 需探索罕见变异和祖先多样化人群。
  • 需改善超越身体残疾测量的疾病严重程度表型。
  • 需厘清可能随环境因素和时间变化的复杂遗传交互。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple sclerosis (MS) is a clinically diverse and unpredictable CNS disorder. The considerable heterogeneity in disease course between people with MS is believed to reflect the varying magnitude and extent of the pathologic processes present at different stages of the disease. Genetic factors are known to contribute to the risk of developing MS and are emerging as predictors of clinical outcomes. They may also offer insights into the biological processes influencing disability. In this review, we evaluate the role of genetic factors in MS from disease susceptibility to disease severity. We consider how understanding of the genetic contribution to the risk of developing MS has evolved to recognize over 230 genetic variants that implicate peripheral immune cells at disease onset. Although MS-risk genes have shown little association with disease severity outcomes, we re-evaluate associations of the main MS-risk allele, HLA-DRB1*1501, with disease activity using observations from long-term longitudinal cohorts. We summarize progress identifying genetic variants associated with clinical phenotypes, including the discovery of the first genetic variant associated with age-related MS severity, rs10191329, and its pathologic associations. We assess the challenges faced by replication studies, including low statistical power, methodologic variations in disability outcomes, and the potential impact from differences in treatment and disease temporality. Reconciling these findings, in contrast to MS-risk genes, MS severity variants appear enriched in CNS tissues, suggesting at least in part distinct genetic architectures for MS risk and severity. Despite advances in our understanding of MS genetics, there remain significant gaps in our knowledge that reflect the elaborate genetic architecture underlying disease progression. Potential gains are to be made from exploring rare variants and ancestrally diverse populations, while the causality of variants may be interrogated through analyses of gene sets and recognized biological pathways. However, further work is required to improve phenotyping of disease severity beyond physical disability measures and to disentangle complex genetic interactions, which may vary with environmental factors and time. Resolving these challenges is crucial if genetic analyses are going to be able to power clinically useable predictive models and inform mechanistic targets for novel treatments in progressive MS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sahi N, Ciccarelli O, Houlden H, et al. Unlocking Multiple Sclerosis Genetics: From Susceptibility to Severity. Neurology. 2025. PMID: 41004698. doi:10.1212/WNL.0000000000214141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。